Marsh & McLennan price target raised to $116 from $112 at JPMorgan » 09:1107/3107/31/20
JPMorgan analyst Jimmy…
JPMorgan analyst Jimmy Bhullar raised the firm's price target on Marsh & McLennan to $116 from $112 and keeps an Overweight rating on the shares. The company's results were "better than expected and healthy" considering the economic backdrop, Bhullar tells investors in a research note. The analyst believes the company is better positioned to navigate the current environment than most property and casualty brokers and underwriters.
Marsh & McLennan reports Q2 adj. EPS $1.32, consensus $1.13 » 07:1607/3007/30/20
Reports Q2 revenue $4.2B,…
Reports Q2 revenue $4.2B, consensus $4.19B. Dan Glaser, President and CEO, said: "In the midst of the pandemic, we delivered another strong quarter reflecting outstanding execution and the resilience of our business. In the second quarter, despite a modest decline in underlying revenue due to the global impact of COVID-19, we generated 10% adjusted operating income growth and 12% growth in adjusted EPS. For the first six months of 2020, we achieved 2% underlying revenue growth and 10% adjusted EPS growth."
|Over a week ago|
Marsh & McLennan raises quarterly dividend to 46.5c from 45.5c per share » 12:1507/1507/15/20
The board of directors of…
The board of directors of Marsh & McLennan declared an increase in the quarterly dividend from 45.5c to 46.5c per share on outstanding common stock, payable on August 14 to stockholders of record on July 27.
|Over a month ago|
Fly Intel: Top five analyst upgrades » 10:1205/1205/12/20
LBTYA, KMX, ES, MMC, CBAY
Catch up on today's…
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Liberty Global (LBTYA) upgraded to Buy from Hold at HSBC. 2. CarMax (KMX) upgraded to Outperform from Neutral at Wedbush with analyst Seth Basham saying he anticipates a stronger bounce-back than previously expected and believes that the company is well positioned to capture market share coming out of the COVID-19 pandemic period. 3. Eversource (ES) upgraded to Buy from Neutral at Janney Montgomery Scott with analyst Michael Gaugler saying despite a mid-March snowstorm that caused significant customer outages, Eversource's Q1 EPS met his expectations and were slightly ahead of consensus. 4. Marsh & McLennan (MMC) upgraded to Overweight from Neutral at Atlantic Equities. 5. CymaBay (CBAY) was upgraded to Outperform from Market Perform at Raymond James and SVB Leerink, to Outperform from In Line at Evercore ISI, and to Buy from Neutral at Stifel and Roth Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
Marsh & McLennan upgraded to Overweight from Neutral at Atlantic Equities » 05:2605/1205/12/20
Atlantic Equities analyst…
Atlantic Equities analyst John Heagerty upgraded Marsh & McLennan to Overweight from Neutral with a $110 price target.
|Over a quarter ago|
Marsh & McLennan valuation more attractive after pullback, says JPMorgan » 09:1105/0105/01/20
JPMorgan analyst Jimmy…
JPMorgan analyst Jimmy Bhullar lowered the firm's price target on Marsh & McLennan to $103 from $108 and keeps an Overweight rating on the shares. The company's Q1 results affirm a bullish stance on the shares, Bhullar tells investors in a research note. Results beat forecasts, but management toned down near-term expectations, adds the analyst. Bhullar feels that while not immune, Marsh & McLennan is better positioned to navigate the current environment than most Property and Casualty brokers and underwriters. Further, the recent pullback bring a more attractive valuation, contends Bhullar.
Marsh & McLennan reports Q1 EPS $1.64, consensus $1.57 » 07:2504/3004/30/20
Reports Q1 revenue $4.7B,…
Reports Q1 revenue $4.7B, consensus $4.68B. Dan Glaser, President and CEO, said, "Marsh & McLennan had an excellent first quarter. We marked the one-year anniversary of our acquisition of JLT and are realizing the benefits of the combination. In the quarter, we grew total revenue 14% and delivered strong underlying revenue growth of 5%, with underlying growth across both Risk and Insurance Services and Consulting. We also increased our adjusted operating income by 15%, adjusted margin by 80 basis points and adjusted EPS by 8%. Although the COVID-19 pandemic will affect all businesses in 2020, Marsh & McLennan has proven to be a resilient firm with unique capabilities, talent and expertise that will allow us to help our clients in this time of need."
Fly Intel: Top five analyst upgrades » 10:2604/1304/13/20
MMC, DNKN, FDX, SO, DHI
Catch up on today's…
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Marsh & McLennan (MMC) upgraded to Buy from Neutral at Goldman Sachs with analyst Yaron Kinar saying the upgrade is predicated on Marsh's positioning for revenue protection and growth, particularly in insurance brokerage. 2. Dunkin' Brands (DNKN) double upgraded to Outperform from Underperform at Credit Suisse with analyst Lauren Silberman saying Dunkin' has underperformed since the market selloff, down 23.5% year-to-date, and is now trading near valuation lows on fiscal 2021 "fresh" consensus estimates. 3. FedEx (FDX) upgraded to Buy from Neutral at BofA with analyst Ken Hoexter saying he believes the recent decision by Amazon (AMZN) to pause its Shipping with Amazon highlights the difficulty of entering the third-party delivery business business. 4. Southern Company (SO) upgraded to Buy from Hold at Argus with analyst Jacob Kilstein citing the company's "well-run base of regulated utility assets" following its recent divestments to focus on core operations. 5. D.R. Horton (DHI) upgraded to Positive from Neutral at Susquehanna with analyst Jack Micenko saying the company is his favorite risk-off name after lowering estimates to account for the pandemic but noting prior to the virus, its buying activity was very hot. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
Marsh & McLennan upgraded to Buy from Neutral at Goldman Sachs » 05:2104/1304/13/20
Goldman Sachs analyst…
Goldman Sachs analyst Yaron Kinar upgraded Marsh & McLennan to Buy from Neutral with a price target of $100, down from $117. The upgrade is predicated on Marsh's positioning for revenue protection and growth, particularly in insurance brokerage, Kinar tells investors in a research note. The analyst expects dissipating new business disruption on the one-year anniversary of the Jardine Lloyd Thompson Group acquisition and alleviating pressure on renewals as well as new opportunities stemming from industry consolidation.
Marsh & McLennan acquires Assurance, terms not disclosed » 09:1804/0104/01/20
Marsh announced that…
Marsh announced that Marsh & McLennan Agency LLC, or MMA, its US middle market agency subsidiary, has acquired Schaumburg, Illinois-based Assurance Holdings. Terms of the acquisition were not disclosed.